HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 193 filers reported holding HAEMONETICS CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $206,000 | -35.4% | 1,800 | -83.6% | 0.00% | 0.0% |
| Q2 2016 | $319,000 | -96.6% | 11,008 | -95.9% | 0.00% | -97.4% |
| Q1 2016 | $9,423,000 | +7.1% | 269,373 | -1.3% | 0.04% | +5.6% |
| Q4 2015 | $8,801,000 | -35.7% | 272,980 | -35.6% | 0.04% | -39.0% |
| Q3 2015 | $13,694,000 | -39.5% | 423,689 | -22.6% | 0.06% | -31.4% |
| Q2 2015 | $22,632,000 | -47.3% | 547,200 | -42.8% | 0.09% | -54.7% |
| Q1 2015 | $42,981,000 | +2.1% | 956,828 | -15.0% | 0.19% | +6.7% |
| Q4 2014 | $42,102,000 | +1.5% | 1,125,132 | -5.3% | 0.18% | +3.5% |
| Q3 2014 | $41,499,000 | -12.5% | 1,188,415 | -11.5% | 0.17% | -13.1% |
| Q2 2014 | $47,402,000 | -15.4% | 1,343,591 | -21.8% | 0.20% | -20.5% |
| Q1 2014 | $56,007,000 | -29.7% | 1,718,538 | -9.1% | 0.25% | -27.0% |
| Q4 2013 | $79,640,000 | -52.0% | 1,890,342 | -54.5% | 0.34% | -21.1% |
| Q3 2013 | $165,752,000 | +88.4% | 4,156,274 | +95.3% | 0.43% | -9.2% |
| Q2 2013 | $87,997,000 | – | 2,128,100 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |